JP2024543214A5 - - Google Patents
Info
- Publication number
- JP2024543214A5 JP2024543214A5 JP2024532831A JP2024532831A JP2024543214A5 JP 2024543214 A5 JP2024543214 A5 JP 2024543214A5 JP 2024532831 A JP2024532831 A JP 2024532831A JP 2024532831 A JP2024532831 A JP 2024532831A JP 2024543214 A5 JP2024543214 A5 JP 2024543214A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163285786P | 2021-12-03 | 2021-12-03 | |
| US63/285,786 | 2021-12-03 | ||
| US202263350206P | 2022-06-08 | 2022-06-08 | |
| US63/350,206 | 2022-06-08 | ||
| US202263398987P | 2022-08-18 | 2022-08-18 | |
| US63/398,987 | 2022-08-18 | ||
| PCT/US2022/051713 WO2023102225A2 (en) | 2021-12-03 | 2022-12-02 | Treatment of neurological diseases using modulators of unc13a gene transcripts |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024543214A JP2024543214A (ja) | 2024-11-19 |
| JP2024543214A5 true JP2024543214A5 (https=) | 2025-12-10 |
| JPWO2023102225A5 JPWO2023102225A5 (https=) | 2025-12-10 |
Family
ID=86613080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532831A Pending JP2024543214A (ja) | 2021-12-03 | 2022-12-02 | Ｕｎｃ１３ａ遺伝子転写物のモジュレーターを使用する神経疾患の処置 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20250051766A1 (https=) |
| EP (1) | EP4441225A4 (https=) |
| JP (1) | JP2024543214A (https=) |
| KR (1) | KR20240129627A9 (https=) |
| CN (1) | CN119790152A (https=) |
| AU (1) | AU2022400851A1 (https=) |
| CA (1) | CA3239482A1 (https=) |
| CL (1) | CL2024001657A1 (https=) |
| CO (1) | CO2024008076A2 (https=) |
| CR (1) | CR20240269A (https=) |
| DO (1) | DOP2024000107A (https=) |
| IL (1) | IL313203A (https=) |
| JO (1) | JOP20240125A1 (https=) |
| MX (1) | MX2024006763A (https=) |
| PE (1) | PE20250677A1 (https=) |
| WO (1) | WO2023102225A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2603454A (en) | 2020-12-09 | 2022-08-10 | Ucl Business Ltd | Novel therapeutics for the treatment of neurodegenerative disorders |
| AU2023356317A1 (en) * | 2022-10-05 | 2025-05-15 | Trace Neuroscience, Inc. | Unc13a antisense oligonucleotides and uses thereof |
| WO2024178223A1 (en) * | 2023-02-24 | 2024-08-29 | Northwestern University | Antisense oligonucleotides for preventing unc13a misplicing |
| WO2025186619A1 (en) * | 2024-03-05 | 2025-09-12 | Takeda Pharmaceutical Company Limited | Compositions and methods for splicing modulation of unc13a |
| WO2025255388A1 (en) * | 2024-06-05 | 2025-12-11 | Camp4 Therapeutics Corporation | Modulation of syngap1 gene transcription using antisense oligonucleotides targeting regulatory rnas |
| WO2026080323A1 (en) | 2024-10-09 | 2026-04-16 | Quralis Corporation | Treatment of neurological diseases using modulators of unc13a gene transcripts |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060008800A1 (en) * | 2001-11-05 | 2006-01-12 | Christian Rosenmund | Unc-13 in the modulation of neurotransmission and secretion events |
| AU2013203395A1 (en) * | 2012-03-30 | 2013-10-17 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulating TAU expression for reducing seizure and modifying a neurodegenerative syndrome |
| DK3155101T3 (da) * | 2014-06-16 | 2020-05-04 | Univ Johns Hopkins | Sammensætninger og fremgangsmåder til ekspression af CRISPR-leder-RNA´er under anvendelse af H1-promotoren |
| WO2020102472A1 (en) * | 2018-11-15 | 2020-05-22 | President And Fellows Of Harvard College | Methods and compositions related to targeting ffar2 and ilc3 populations for the treatment of a gastrointestinal disease |
| AU2022255175A1 (en) * | 2021-04-06 | 2023-11-23 | Trace Neuroscience, Inc. | Compositions and methods for treating tdp-43 proteinopathy |
-
2022
- 2022-12-02 CN CN202280090919.7A patent/CN119790152A/zh active Pending
- 2022-12-02 AU AU2022400851A patent/AU2022400851A1/en active Pending
- 2022-12-02 MX MX2024006763A patent/MX2024006763A/es unknown
- 2022-12-02 EP EP22902264.5A patent/EP4441225A4/en active Pending
- 2022-12-02 JP JP2024532831A patent/JP2024543214A/ja active Pending
- 2022-12-02 PE PE2024001294A patent/PE20250677A1/es unknown
- 2022-12-02 CA CA3239482A patent/CA3239482A1/en active Pending
- 2022-12-02 IL IL313203A patent/IL313203A/en unknown
- 2022-12-02 US US18/715,644 patent/US20250051766A1/en active Pending
- 2022-12-02 WO PCT/US2022/051713 patent/WO2023102225A2/en not_active Ceased
- 2022-12-02 KR KR1020247021710A patent/KR20240129627A9/ko active Pending
- 2022-12-02 CR CR20240269A patent/CR20240269A/es unknown
-
2024
- 2024-06-02 JO JOJO/P/2024/0125A patent/JOP20240125A1/ar unknown
- 2024-06-03 DO DO2024000107A patent/DOP2024000107A/es unknown
- 2024-06-03 CL CL2024001657A patent/CL2024001657A1/es unknown
- 2024-06-21 CO CONC2024/0008076A patent/CO2024008076A2/es unknown